2010, Number 1
<< Back Next >>
An Med Asoc Med Hosp ABC 2010; 55 (1)
Giant retroperitoneal liposarcoma
Hernández PRE, Ortiz PJ, Orozco P, Wellman R
Language: Spanish
References: 20
Page: 38-41
PDF size: 207.19 Kb.
ABSTRACT
Sarcomas represent less than 1% of malignant tumors, and only 10 to 15% are found in the retroperitoneum. The most frequently found tumors in the retroperitoneum are malignant fibrous histiocytoma, liposarcomas and leiomyosarcomas. The cornerstone for treatment this type of tumors is surgery, and size does not represent a contraindication for it.
Case report: 30 year old female patient with history of slow abdominal growth for the last 4 years, accompanied by weight loss and early satiety. She was operated removing a tumor weighting 20 kg.
Conclusions: Size of retroperitoneal tumors should not represent a contraindication for surgical treatment. Whenever a multiorganic resection is feasible, a complete macroscopic resection should be contemplated.
REFERENCES
Mack TM. Sarcomas and other malignancies of soft tissue, retroperitoneum, peritoneum, pleura, hart, mediastinum, and spleen. Cancer 1995; 75: 211-244.
Clark JA, Tepper JE. Role of radiation therapy in retroperitoneal sarcomas. Oncology 1996; 10: 1867-1872.
Surg Oncol Clin N Am 2003; 12: 369-377.
Lewis JJ, Leung D, Woodruff JM, Brennan ME. Retroperitoneal sarcoma: Analysis of 500 patients treated and followed at a single institution. Ann Surg 1998; 228: 335-365.
Coddy HS, Turnbull AD, Fortner JG et al. The continuing challenge of retroperitoneal sarcomas. Cancer 1981; 47: 2147-2154.
Singer S, Corson JM. Demnetri GD et al. Prognostic factors predictive of survival for truncal and retroperitoneal soft tissue sarcoma. Ann Surg 1995; 222: 185-195.
Meis-Kindblom JM, Sjogren H, Kindblom LG et al. Cytogenetic and molecular genetic analysis of liposarcoma and soft tissue simulators; recognition of new variants and differential diagnosis. Virchows Arch 2001; 439: 141-151.
Kilkenny JW, Bland KU, Copeland EM. Retroperitoneal sarcoma; University of Florida experience. J AM Coll Surg 1996; 182: 329-339.
Boeing CC, Squires TS, Tong T, Montgomery S. Cancer statics, 1994. CA Cancer J Clinic 1994; 44: 7-26.
Jaques DP, Coit DG, Hajdu SI et al. Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum. Ann Surg 1990; 212: 51-59.
Karakousis CD, Gerstenblunth R, Kontzoglou K et al. Retroperitoneal sarcomas and their management. Arch Surg 1995; 130; 1105-1109.
Loannidis JP, Lau J. 18-F-FDG PET for the diagnosis and grading of soft-tissue sarcoma a meta-analysis. J Nucl Med 2003; 44: 717-724.
Lucas JD, O doherty MJ, Croin BF, Marsden PK, Lodge MA, McKee PH. Prospective evaluation of soft tissue masses and sarcomas using fluorodeoxyglucosa positron tomography. Br J Surg 1999; 86: 550-556.
Alvaregenga JC, Ball ABS, Fisher C et al. Limitations of surgery in the treatment of retroperitoneal sarcomas. Br J Surg 1991; 78: 912-916.
Jaques DP, Coit DG, Haddu SI et al. Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum. Ann Surg 1990; 212: 51-59.
Dalton RR, Donohue JH, Mucha P Jr et al. Management of retroperitoneal sarcomas. Surgery 1989; 106: 725-733.
Pawlik TM et al. Long-term result of two prospective trials of preoperative external beam radiotherapy for localized intermediate – or high grade retroperitoneal soft tissue sarcoma. Ann Surg Oncol Vol 2006; 13 (14).
Willet CG, Suit HD, Tepper JE et al. Intraoperative electron beam radiation therapy for retroperitoneal soft tissue sarcomas. Cancer 1991; 8: 278-284.
Sarcoma Meta-analysis Collaboration. Adjuvant chemotherapy for localized resecable soft-tissue sarcomas of adults: Metaanalysis of individual data. Lancet 1997; 350: 1547-1554.
Feig BW. Retroperitoneal sarcomas. Surg Oncol Clin N Am 12: 2003: 369-377.